Outcomes After Perioperative Stroke Following Cardiac Surgery
NCT ID: NCT05333146
Last Updated: 2022-06-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
906 participants
OBSERVATIONAL
2022-04-18
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of Outcome After Perioperative Stroke
NCT04214613
Impact of Cerebral Monitoring on Neurologic Outcome in Cardiac Surgery
NCT02006212
Incidence and Risk Factors of Peri-operative Stroke in Non-cardiac,Non-neurosurgical Surgeries
NCT01758952
Postoperative Cognitive Dysfunction in Geriatric Patients
NCT00512200
Opioid Reduced Anesthesia With Parasternal CATheters on Postoperative Delirium After Cardiac Surgery
NCT05880615
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
OBJECTIVES
1. Derive and externally validate risk prediction models for mortality (primary outcome), adverse discharge, and length of stay after perioperative stroke.
2. Describe temporal trends in mortality after perioperative stroke between 2005 and 2020.
METHODS This study is a retrospective analysis of the prospectively-collected American College of Surgeons National Surgical Quality Improvement Program database between 2004 and 2020. The study cohort will be extracted from the NSQIP database and include all patients who experienced a stroke within 30 days of surgery and who underwent a cardiac surgical procedure.
STUDY POPULATION Patients who underwent any cardiac surgical procedure and who experienced a perioperative stroke in the NSQIP database between 2005 and 2020 will be included.
OUTCOMES Primary outcome is 30-day mortality; secondary outcomes are length of hospital stay and adverse discharge (non-home facility or death).
Candidate predictor variables: Outcome after perioperative stroke is potentially related to patient, surgical, and anesthetic factors, as well as characteristics of the stroke. Candidate predictor variables will include patient characteristics (age, sex, comorbidities), surgical characteristics (complexity, type, emergency status, aortic surgery), postoperative complications (cardiac arrest, myocardial ischemia, transfusion) and stroke characteristics (severity as determined by associated tracheostomy or craniectomy), timing relative to operation, readmission for stroke vs inpatient stroke). Continuous variables will be considered for transformation using fractional polynomials to allow a continuous non-linear association.
ANALYSIS Multivariable models to predict 30-day mortality (primary outcome), adverse discharge and length of stay will be created. To avoid over-fitting, we will undertake a data reduction strategy and exclude variables with greater than 10% missing data or less than 20 observations, where \>1% but \<10% data are missing, we will consider multiple or mean imputation.
Pre-specified predictor variables will be used to construct a logistic regression model using a principle component analysis. We will a priori examine the following interactions: age\*gender, surgical complexity (operation time)\*age. Given the potential differential mechanisms of early (\<48h) and late (\>48h and \<30 days) perioperative stroke, we will include days from surgery to event as both a continuous and categorical variable.
Model discrimination will be evaluated using the area under the receiver operating characteristic curve (c-statistic). Model calibration will be assessed with a loess smoothed plot of observed vs predicted risks over the risk spectrum. A similar analysis will be used to create a prediction model for length of stay. As death is a competing outcome for discharge disposition, adverse discharge will be modelled as an ordinal outcome (home, non-home discharge, or death). Following derivation, 5,000 bootstrap samples will be used for internal validation.
Temporal trends in mortality will be analyzed first using an exploratory unadjusted ordinary least squares regression model with annual mortality rate after perioperative stroke as the dependent variable and year as the predictor to estimate the yearly change in mortality rate over time. A multivariable linear regression model will be specified, adjusting for important predictors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac Surgery
Cardiac surgery (e.g. coronary bypass surgery, cardiac valve surgery, ascending aortic surgery)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Underwent cardiac surgery
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alana Flexman
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alana Flexman, MD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of British Columbia
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Alana Flexman, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H21-03915
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.